✦ LIBER ✦

ChemInform Abstract: Nonpeptide GPIIB/IIIA Inhibitors. Part 10. Centrally Constrained alpha- Sulfonamides are Potent Inhibitors of Platelet Aggregation.

✍ Scribed by M. S. EGBERTSON; G. D. HARTMAN; R. J. GOULD; B. BEDNAR; R. A. BEDNAR; J. J. COOK; S. L. GAUL; M. A. HOLAHAN; L. A. LIBBY; J. J. JUN. LYNCH; R. J. LYNCH; G. R. SITKO; M. T. STRANIERI; L. M. VASSALLO

Publisher: John Wiley and Sons
Year: 2010
Weight: 31 KB
Volume: 28
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.199714120

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Nonpeptide GPIIb/II

ChemInform Abstract: Nonpeptide GPIIb/IIIa Inhibitors. Part 16. Thieno(2,3-b)thiophene . alpha.-Sulfonamides are Potent Inhibitors of Platelet Aggregation.

✍ J. D. PRUGH; R. J. GOULD; R. J. LYNCH; G. ZHANG; J. J. COOK; M. A. HOLAHAN; M. T 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 32 KB 👁 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v

ChemInform Abstract: Nonpeptide Glycopro

ChemInform Abstract: Nonpeptide Glycoprotein IIB/IIIA Inhibitors. Part 18. Indole α-Sulfonamide Acids are Potent Inhibitors of Platelet Aggregation.

✍ K. M. BRASHEAR; J. J. COOK; B. BEDNAR; R. A. BEDNAR; R. J. GOULD; W. HALCZENKO; 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 31 KB 👁 1 views

ChemInform Abstract: Fibrinogen Receptor

ChemInform Abstract: Fibrinogen Receptor (GPIIb-IIIa) Antagonists Derived from 5,6-Bicyclic Templates. Amidinoindoles, Amidinoindazoles, and Amidinobenzofurans Containing the N-α-Sulfonamide Carboxylic Acid Function as Potent Platelet Aggregation Inhibitors.

✍ T. SU; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 34 KB 👁 1 views

Structural optimization of amidinoindole and amidinobenzofuran carboxylic amides leads to a series of compounds, among which analogues (I)-(III) exhibit potent in vitro activity in platelet aggregation assays and function as very potent and specific GPIIb-IIIa antagonists. -(SU, T.